These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6398944)

  • 1. Aldosterone-stimulating factor is increased in idiopathic hyperaldosteronism.
    Dolan LM; Malchoff CD; Sen S; Carey RM
    Trans Assoc Am Physicians; 1984; 97():10-8. PubMed ID: 6398944
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.
    Carey RM; Sen S; Dolan LM; Malchoff CD; Bumpus FM
    N Engl J Med; 1984 Jul; 311(2):94-100. PubMed ID: 6330549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pheochromocytoma with hyperaldosteronism and abnormalities of humoral immunity. Study of plasma renin activity].
    Néel JL; Loubrieu G; Menagé JJ
    Sem Hop; 1977 Oct; 53(36):1959-63. PubMed ID: 208164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary hyperaldosteronism].
    Veyrat R; Muller AF; Mach RS
    Schweiz Med Wochenschr; 1968 Jan; 98(3):65-75. PubMed ID: 4299459
    [No Abstract]   [Full Text] [Related]  

  • 5. [The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism].
    Frisina N; Buemi M; Ciraolo O; Naso G; Lasco A; Costa G
    Boll Soc Ital Biol Sper; 1980 Nov; 56(22):2284-8. PubMed ID: 7013771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations.
    Ganguly A; Grim CE; Bergstein J; Brown RD; Weinberger MH
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1040-6. PubMed ID: 7026592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renin studies in idiopathic edemas with secondary hyperaldosteronism].
    Veyrat R; Robert M; Mach RS
    Schweiz Med Wochenschr; 1968 Sep; 98(39):1499-507. PubMed ID: 5701067
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hyperaldosteronism in childhood].
    Cserháti E; Körner A
    Orv Hetil; 1980 Jun; 121(24):1453-5. PubMed ID: 6108546
    [No Abstract]   [Full Text] [Related]  

  • 10. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of primary hyperaldosteronism].
    Diederich S; Bidlingmaier M; Quinkler M; Reincke M
    Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic edemas with secondary hyperaldosteronism. Definition, history, pathogenesis].
    Veyrat R
    J Urol Nephrol (Paris); 1970 Dec; 76(12):969-84. PubMed ID: 5511433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Normokalemic primary hyperaldosteronism].
    Vonend O; Rump LC
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H24-7. PubMed ID: 17109245
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism.
    Kaplan NM
    J Hypertens; 2006 Sep; 24(9):1899; author reply 1899-900. PubMed ID: 16915042
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the aldosterone-renin ratio useful in screening for primary aldosteronism?].
    Kreze A; Okálová D; Hrnclar J
    Vnitr Lek; 1996 Sep; 42(9):649-51. PubMed ID: 8984776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden.
    Westerdahl C; Bergenfelz A; Isaksson A; Wihl A; Nerbrand C; Valdemarsson S
    Scand J Prim Health Care; 2006 Sep; 24(3):154-9. PubMed ID: 16923624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renin and aldosterone regulation in idiopathic edemas].
    Werning C; Siegenthaler W
    Bratisl Lek Listy; 1972 Apr; 57(4):385-92. PubMed ID: 5018682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.